Clinical Nutrition Market Size and Share by Product (Infant Nutrition, Enteral Nutrition, Parenteral Nutrition), End User (Pediatric, Adult, Geriatric), Distribution Channel (Pharmacies & Drug Stores, Online Channels), Application (Cancer, Metabolic Disorders, Gastrointestinal Diseases, Neurological Disorders) - Global Industry Trends and Demand Forecast to 2030

Market Overview

The global clinical nutrition market size in 2021 was $37.8 billion, and it is expected to advance at a CAGR of 7.2% during 2021–2030, to reach $70.8 billion by 2030. The industry is experiencing significant growth as a result of an aging population, a high birth rate and a high number of premature births, an increase in the number of malnutrition victims, a rise in the incidence of lifestyle-related diseases, and athletes' adoption of sports nutrition products due to their benefits.

Clinical nutrition is a science that studies how nutrients are ingested, processed, utilized, and excreted by the body. It is primarily concerned with managing the dietary needs of both inpatients and outpatients, in order to maintain a healthy nutritional balance. Also, it is an essential component for the treatment of both acute and chronic illnesses, allowing for faster recovery and improved patient health.

Clinical nutrition spending is likely to rise in the future as the senior population grows. Because of the feeble digestive framework of old age, it becomes difficult for the human body to assimilate all of the needed nutrients from meals. Loss of appetite is a big general problem among the senior population, causing them to miss out on critical nutrients. As a result, the senior population is increasingly reliant on clinical nutrition support to obtain necessary vitamins.

Competitive Scenario

Continuous expansion and increase in the monetary value of key operating companies give them a competitive edge for the development of new solutions. Furthermore, corporations are continually working to improve their current product line in order to maintain their position. Thus, companies' new medicine development and foray into undeveloped regions to broaden their reach are likely to drive the industry.

Increasing Demand for Clinical Nutrition in Emerging Economies

• Developing economies of APAC, MEA, and LATAM, such as India and Brazil, provide considerable growth potential to the market. Key players are pouring money toward expanding their footprint in these countries. The need for clinical nutrition in these nations is quickly expanding, creating abundant growth prospects for both established firms and new entrants. Furthermore, the rising compliance for homecare medical services and the expanding awareness of nutrition products are driving clinical nutrition market demand.
• Despite the fact that the market in APAC, MEA, and LATAM is quickly expanding, the healthcare sector in these regions remains untapped for clinical nutrition. This broadens the possibility for growth in demand in these countries and attracts new investors and new players to exploit the potential of the market.

End User Analysis

The consumption of clinical nutrition is the highest among newborns under the age of one in the pediatric population. The average hospital stay is shorter for pediatric patients than it is for adults and the elderly. Parents place a high priority on the well-being of their children, which forces them to spend more money on their treatment. In order to save unnecessary medical costs, parents are looking for ways to keep their children healthy. These safety precautions may pave the way for the clinical nutrition sector in the pediatric category.

Moreover, due to the surging number of adult persons with chronic conditions, the adult category accounted for significant revenue, of more than 60%, in 2021. The adult population is becoming more aware of the disease treatment alternatives that are available. This aspect increases the number of clinical nutrition clinics for adults, combined with attractive medical insurance policies and improved access to cutting-edge healthcare facilities.

As people get older, their digestive system’s capacity for absorption decreases, making it more difficult for the body to absorb all the nutrients it needs from food. Appetite loss is a prevalent problem among elderly people. As a result, seniors do not receive the recommended amounts of vitamins. They now rely on additional supplements for a balanced diet. The main issues affecting the older population, for which they need nutritional support, are the weakening of bones, poor digestive health, immobility, and chronic and degenerative diseases. Thus, the older population is becoming more dependent on therapeutic nutrition support to keep healthy.

Application Analysis

The cancer category is growing significantly in the market, due to the rising cancer incidence worldwide. Products for enteral nutrition are regarded as one of the greatest solutions for treating cancer, preventing nutritional deficiencies in the body, and ensuring the proper operation of numerous organs. Cancer patients need a healthy diet because the disease might alter how their bodies process nutrients. Patients must get continual nutrient feedings since cancer patients may become malnourished and lose weight.

Furthermore, patients with neurological illnesses must consume nutrients properly, which is why enteral nutrition products are in high demand. The benefits of nutritional goods in the healing process and their affordability are fueling the market expansion. This is also because people become more aware of the connection between health and nutrition.

The need for clinical nutrition is also expanding along with the prevalence of metabolic diseases. In adults and the elderly, the prevalence of metabolic illnesses is quickly rising. Numerous nations have had serious concerns about diabetes. In the treatment of metabolic diseases, nutrition is crucial. In addition, the market growth is supported by the surging prevalence of metabolic disorders and the launch of new products.

Moreover, due to the rise in the prevalence of gastroenteritis, Crohn's disease, and irritable bowel syndrome, the gastrointestinal diseases category is expected to rise at a CAGR of more than 8% in the coming years. This can be because these illnesses will encourage people to take therapeutic nutrition supplements for gastrointestinal ailments.

Explore more about this report - Request free sample pages

Regional Analysis

In 2021, North America accounted for the majority of clinical nutrition product sales, around 40%. High rates of cancer and disorders linked to a sedentary lifestyle, a large number of participants, and superior reimbursement policies in comparison to other regions are some of the key factors propelling the market expansion. Additionally, the region's high disposable income, well-developed healthcare infrastructure, and high healthcare expenditures are all contributing to the demand for clinical nutrition.

In terms of revenue share, Europe constituted significantly to the market. This is due to the rise in the aging population, high cancer incidence, and high birth rate in various nations like the U.K. and France, in the region. The industry growth is being aided by the developed healthcare infrastructure and high healthcare expenditures in Europe.

On the other hand, during the projection period, the APAC market is expected to experience the highest CAGR, of more than 9%. This can be attributed to the rising birth rate, growing geriatric population, and high malnutrition rates in the region. The demand for therapeutic nutrition products is also expected to rise as the region's malnutrition treatment cases increase. Furthermore, the clinical nutrition market growth in APAC is predicted to be fueled by surging disposable income, rising healthcare costs, and growing nutrition awareness.

LATAM will have a sizable revenue share in the market in the coming years. This can be because of a huge population that is undernourished, improving healthcare infrastructure, and decreasing prices for enteral nutrition products. Moreover, MEA will also generate significant demand for clinical nutrition, due to the rising healthcare costs, premature births, and increasing chronic illness incidences in the region.

Top Clinical Nutrition Manufactures Are:

• Abbott Laboratories
• Nestlé S.A.
• Perrigo Company plc
• Danone S.A.
• Pfizer Inc.
• Reckitt Benckiser Group plc
• Kraft Heinz Company

Global Clinical Nutrition Market Size Breakdown by Segment

The study offers a comprehensive market segmentation analysis along with market estimation for the period 2017-2030.

Based on Product

• Infant Nutrition
• Enteral Nutrition
• Parenteral Nutrition

Based on End User

• Pediatric
• Adult
• Geriatric

Based on Application

• Food and Beverage
• Pharmaceutical

Based on Distribution Channel

• Pharmacies & Drug Stores
• Online Channels

Based on Application

• Cancer
• Metabolic Disorders
• Gastrointestinal Diseases
• Neurological Disorders

Geographical analysis

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
• Asia-Pacific
  • Japan
  • China
  • India
  • South Korea
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • Saudi Arabia
  • South Africa